Patients diagnosed with any PCa (GGG1) and csPCa (GGG≥2) were older, had greater PSA and PSA density suspicious DRE and Qmax, but lower prostate volume, PVR and IPSS than those without cancer. This evidence concerns the gene KLK3 and posterior cortical atrophy.